| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8be5426d28d133971ca0924ed527ea46 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate |
2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e18dd14936697b02e5001a5a6d7efb3 |
| publicationDate |
2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104072434-A |
| titleOfInvention |
Meta-substituted tetrazole acetophenone compound, its preparation method and use |
| abstract |
The invention relates to the field of medicine related to thrombotic diseases. Specifically, the present invention relates to a class of meta-substituted PAR-1 antagonists containing tetrazole acetophenone structures, their preparation methods, pharmaceutical compositions containing them, and their role in the preparation of drugs for treating thrombotic diseases. application. (I) The definition of the R group is as described in the description. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104496925-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104513212-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104513212-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104529928-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104529930-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104496927-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104478819-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104496923-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104529930-A |
| priorityDate |
2014-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |